The effect of serotonin (5-HT) and its antag onist ketanserin on the cerebral circulation was investi gated in two series totaling 24 cats using the cranial window technique, 5-HT elicited a marked dilatation of small pial arteries, whereas large arteries tended to con strict. Intravenous administration of ketanserin reversed the constriction of large arteries, causing dilatation, and reduced the extent of small arteries' dilatation, In a ran domized study, i.v. administration of ketanserin in its sol vent versus the solvent alone revealed a strong dilatatory
Serotonin (5-HT) , a monoamine with a well known central nervous system neurotransmitter function (Niewenhuys et aI., 1981) , has been de scribed as one of the potential candidates in the pathogenesis of cerebral arterial spasm from sub arachnoid hemorrhage and migraine because of its potent constrictor effect on large cerebral arteries, the latter being angiographically seen to be nar rowed under the above-mentioned clinical circum stances. In vitro experiments showed strong con strictory effects on large intracranial extracerebral arteries (Allen et aI., 1974; Edvinsson and Owman, 1975; Silverberg et aI., 1977; Edvinsson et aI., 1979; Welch and Helpern, 1981; McCalden and Bevan, 1982; To wart and Kazda, 1982) . lntracarotid injec tions in vivo caused angiographically visible con traction of the internal carotid artery; however, there was no change in blood flow (Harper and MacKenzie, 1977a) . This seemingly contradictory result of cerebral arterial constriction and un changed blood flow under normal circumstances has stimulated further work on the effects of 5-HT effect of the solvent on pial arteries (17 ± 1.8%), which partly jeopardized a possible constrictory effect of ketan serin, as ketanserin plus solvent induced less dilatation of small pial arteries than the solvent alone. The present data support the view that serotonin exerts a dual effect on cerebral arteries, namely, dilatation of small and con striction of large vessels. The antagonist ketanserin re verses this effect, but the strong dilatatory effect of the solvent alone masks the antiserotoninergic effect. Key Words: Ketanserin-Pial vessels-Serotonin.
in pathological conditions such as hypercapnia, damage to the blood -brain barrier (Harper and MacKenzie, 1977a) , and addition of subarachnoid blood (Boisvert et aI., 1979; Svendgaard et aI., 1979) . From such observations it was concluded that 5-HT could exert a detrimental effect that was dependent on vessel wall tension, the integrity of the blood-brain barrier, and a hypersensitive state of cerebral vessels to physiological concentrations of 5-HT. This possibly pathogenetic role of 5-HT in the cerebral circulation, as well as a causal rela tionship to certain cases of chronic hypertension, have led to the development of pharmacological compounds able to antagonize such constrictory ef fects.
In the present study, the 5-HT-2 antagonist ke tanserin has been investigated for its effect on in tracranial extraparenchymal resistance and precap illary vessels, with and without the addition of 5-HT to the subarachnoid space of experimental an imals. On this occasion, the effect of subarachnoi dally administered 5-HT on pial vessels was rein vestigated in view of contradictory reports in recent literature (Rosenblum, 1975; Harper and Mac Kenzie, 1977b; Thompson et aI., 1984) .
MATERIALS AND METHODS
In two different series of cats with a body weight of 1.5-3 kg, totaling 24 animals, anaesthesia was induced with 30 mg kg-I sodium pentobarbital. After the comple tion of the surgical preparation, anaesthesia was con tinued with a 3:1 N20:02 mixture after endotracheal in tubation and relaxation with 60 f.Lg kg-I pancuronium bromide.
Both femoral arteries and one femoral vein were can nulated for continuous recording of mean arterial pres sure (MAP), arterial blood sampling for measurements of PP2' Paco2, and pH (AVL type 937C blood gas analyzer); the venous catheter was used for drug administration. Body temperature was maintained between 37°C and 38°C using continuous rectal thermosensor recording and a heating pad.
With the animal in sphinx position, a cranial window was made in the left parietal region, closed with a cover glass and sealed with acrylic (Auer, 1978) . Diameter vari ations of pial vessels were continuously registered using a Leitz intravital microscope and a multichannel videoan giometer device (Auer and Haydn, 1979) .
Series 1
In addition to the cranial window in six animals, a PVC catheter was placed with the tip in the subdural space of the window and was connected to a low volume perfusion pump. A 10-4 M solution of 5-HT (E. Merck, Darmstadt, F.R.G.) in mock cerebral spinal fluid (CSF), as de scribed by Kuschinsky and Wahl (1978) , was infused with a volume of 0.1 ml min -I until a new steady state of vessel calibers was achieved. While superfusion was con tinued, slow intravenous injection of the 5-HT-2 antago nist ketanserin (compound provided by Janssen, Beerse, Belgium) at a dose of 1 mg kg -I was performed, and reac tions were observed over a further 20 min. A second can nula was placed into the great cistern to allow the balance of CSF pressure. Six animals served as controls and were superfused with 0.1 ml min -I mock CSF for 30 min. The artificial CSF was composed of 156 mM Na +, 3 mM K +, 1.5 mM Ca 2 +, 15 mM HCO-;-, 147 mM Cl-and was bub bled with 95% O2 and 5% CO2, The solvent for ketanserin contained 1.1 mg tartaric acid and 51.8 mg propylene glycol per 6.9 mg ketanserin tartrate in 1 ml HzO.
Series 2
In a study on 12 animals, 1 mg kg-I ketanserin or its solvent were intravenously administered in a randomized manner, and pial vessel caliber variations were observed over 20 min. Intracranial pressure was continuously reg istered via a cannula in the great cistern.
Throughout the experiments Pao2 and Paco2 were main tained at normal levels (Table 1) .
Small pial arteries are defined as vessels with resting calibers up to 100 fl,m, large ones> 100 f.Lm. The range of vessel sizes in series 1 was 20-259 f.Lm in 63 arteries and 40-240 f.Lm in 63 veins. In series 2, 60 arteries had resting sizes of 40-212 f.Lm and 63 veins, 43-216 f.Lm (Table 2) .
Statistical calculations were performed with analysis of variance and regression analysis. Mean values in the text are accompanied by SEM.
RESULTS
Resting values of small and large pial arteries and veins, as well as MAP from treated animals and controls, are shown in Ta bles 1 and 2.
Series 1 5-HT dilated small arteries markedly, and the smaller the resting caliber, the greater the dilata tion. Arteries larger than 200 /-Lm showed a very minor reaction or tended to constrict. This inverse correlation of resting caliber and percentage reac tion was statistically significant (Fig. 1) .
Superfusion with mock CSF in controls induced no reaction during the first 10-20 min; however, toward 30 min, it elicited a 3 and 6% dilatation of small and large arteries, respectively. Figure 2 shows the marked dilatation of small arteries to 5-HT; after i. v. injection of ketanserin in its solvent, the degree of dilatation of small arteries remained unchanged, whereas large arteries continued to di late from + 12.4 ± 5 (effect of 5-HT) to 19. 5 ± 4% during infusion of additional ketanserin in its sol vent. However, the number of dilating vessels was reduced, some going back to baseline, others even constricting, ending at a lower level of mean dila tation of small arteries. Under ketanserin, the regression line of the percentage of dilatation versus resting caliber ( Fig. 1) flattened to a line parallel to the x axis at 16% dilatation, indicating a statistically significant reduction in dilatation of small arteries as well as abolishment of the tendency of large ar teries to constrict.
A similar tendency seen in arterial reactions was noted in pial veins, although to a lesser degree, as described elsewhere in detail (Leber et al., 1983) . Again, small vessels dilated and large ones were unreactive or tended to constrict, depending on their resting caliber. Small veins dilated by 1. 3 ± 2. 7, large veins by 5 ± 1.5%. Ketanserin induced no change in diameters. As shown in Ta ble 2 and Fig. 3 , ketanserin in duced a significant 38% fall in MAP, from 131 ± 10 to 81 ± 8 mm Hg.
Series 2
The influence of ketanserin in its solvent or the solvent alone on heart rate, MAP, and intracranial pressure (ICP) is depicted in Fig. 3 . Although ICP remained unchanged and normal throughout, as well as MAP and heart rate in the solvent-treated group, ketanserin induced a sharp 41% fall in MAP, from 134 ± 9 to 78 ± 7. 5 mm Hg; moreover, heart rate was markedly reduced by some 20 beats/min under ketanserin.
Pial arteries exhibited significant dilatation, which increased over time and was more marked with the solvent alone than with ketanserin plus sol vent (Fig. 4) ; thus, the 9. 5 ± 1. 3% dilatation of arteries in the solvent group was significantly higher than the 5. 7 ± 1. 7% in the ketanserin group 10 min after injection of ketanserin. After 20 min, the solvent-induced arterial dilata tion rose to 17 ± 1.9%, markedly, though insignif icantly, more than the 12.9 ± 2. 3% in the ketanserin group.
In contrast, pial venous reactions were very modest (Fig. 4) . Figure 5 shows a comparative plot of arterial resting calibers versus the percentage of reaction under ketanserin or its solvent. There is no difference in the reaction pattern between small and large arteries in either group; the regression lines are similar to the regression line of ketanserin in Fig. 1 . 
DISCUSSION
The present study shows a distinct dilatation of small pial arteries under the influence of 5-HT, whereas arteries larger than 200 fLm tended to con strict. This observation is in agreement with pre vious data by Harper and MacKenzie (1977 b) and MacKenzie et al. (1977) , who also found dilatation of pial arteries smaller than 70 fLm and a tendency to constriction in pial arteries larger than 200 fLm. There may also be agreement with the data of Bois vert et al. (1979) from in vivo studies in monkeys, which showed no response, on the average, of pial arteries following subarachnoid injection of 5-HT, assuming that an equal number of arteries larger and smaller than 200 fLm have been observed. In contrast to the response of small arteries, intravas cularly administered 5-HT caused a profound con striction of the internal carotid artery (Harper and MacKenzie, 1977a) and of large intracranial extra cerebral arteries in vivo (Kuwayama et al., 1972; Zervas et al., 1973) . This dual response explains the unchanged cerebral blood flow (Harper and MacKenzie, 1977a; MacKenzie et al., 1977; Men delow et al., 1977) . Vessels above 200 fLm caliber which would normally constrict with 5-HT, have a blood -brain barrier, causing them to remain unre sponsive to the application of 5-HT. However, as soon as 5-HT is given perivascularly or intravas cularly during osmotic opening of the blood-brain barrier, these resistance vessels are also constricted by 5-HT and cerebral blood flow is now reduced (MacKenzie et al., 1976; Harper and MacKenzie, 1977a; MacKenzie et al., 1977; Boisvert et al., 1979; Grome and Harper, 1981) .
In the same situation, small pial veins are also slightly, but significantly, dilated by some 8%. As 70-80% of cerebral blood volume is located in the veins (Mellander and Johansson, 1968 ) and most of this is in the small veins, the behavior of vessels could be responsible for an increase in cerebral blood volume. This could explain the clinical ob servations by Martin et al. (1984) of decreased ce rebral blood flow, together with increased cerebral blood volume, in patients after subarachnoid hem orrhage.
The pH of the cerebrospinal fluid is known to have a potent influence on pial arterial calibers (McCulloch et al., 1982) ; an increase in pH to 7.6 would have to cause marked constriction in the al-kaline milieu. This is probably prevented in the present experiments due to the extremely low volume of the solution delivered during the 20 min of observation and dissolved in the animal's own CSF. Above all, a pH of the 5-HT solution in mock CSF of 7.6, as well as a pH of 7.43 of mock CSF alone, cannot account for pial arterial dilatation.
Intravenous administration of ketanserin reduced the 5-HT -induced dilatation of small pial arteries; a similar range of 8-12% dilatation was observed with and without perivascular 5-HT. However, an even higher degree of dilatation was evoked by in travenous treatment with the solvent alone. Thus, the effect of the whole compound (ketanserin plus solvent) is probably an underestimation of the real effect of ketanserin alone. It is assumed that part of a possible ketanserin-induced constriction of small pial arteries might be jeopardized by (a) the dilatatory effect of the solvent and (b) the auto regulatory dilatation in answer to the ketanserin induced fall in MAP.
The observation that ketanserin reversed the 5-HT -induced constriction of large arteries as well as the dilatation of small arteries, gives further sup port to the above-mentioned dual behavior of ce rebral arteries: ketanserin-induced dilatation of large arteries thus counteracting 5-HT -induced constriction, and thus causing a reduced dilatation in small arteries. The assumption of an anti-5-HT effect of ketanserin is supported by the present data despite the masking effect of the solvent.
The slight dilatatory effect of the solvent of ke tanserin on the pial veins can be interpreted as a passive dilatation due to the increase in arteriolar volume. Similarly, the significantly lower venous volume under the influence of ketanserin could be passive behavior due to the lower volume on the arterial side. The assumption of passive behavior of pial veins is supported by an unpublished in situ study (McCulloch, unpublished observations) showing no response of pial veins to 5-HT. Other recent investigations by Thompson et al. (1984) showed a similar effect of ketanserin. However, perivascular application of 5-HT in those experi ments caused constriction of both large and small pial arteries, which is in contrast to the present data as well as those of Harper and MacKenzie (1977b) . Three of four possible explanations offered by Thompson et al. (1984) to account for the discrep ancy with Harper and MacKenzie (1977b) namely, type of anaesthesia, open versus closed cranial window, and microapplication versus super fusion of 5-HT -are not valid, because the present study is identical to Thompson's experiments in these three points. As a fourth possibility, Thompson et al. mention a difference in the com position of artificial CSF. Unfortunately, the authors did not indicate the composition of their CSF and pH, nor was there a control group to compare the net effect of artificial CSF from Thompson's study with the present control group. In addition, when using the cranial window technique, it is not self evident that pial vessel calibers remain unchanged during a longer period of observation under normal conditions. The use of a control group might thus be helpful for better comparability of studies in the future. The important effect of pH changes (Mc Culloch et aI. , 1982) makes it plausible to assume a discrepancy between the studies due to an differ ence in CSF composition. Alternatively, a consid erable difference in the reactions of pial vessels might occur between superfusion with intact versus opened arachnoid membrane; in the present model, the arachnoid membrane was opened and CSF al lowed to fill up the cranial window, before it was closed with a cover glass.
In conclusion, the present data support the hy pothesis that 5-HT constricts large pial arteries and dilates small pial arteries. The effect of the 5-HT antagonist ketanserin given intravenously is jeop ardized to a great extent by the solvent used for this compound. However, data suggest that both the ef fects of 5-HT on cerebral arteries could be reversed by ketanserin in a solvent that does not influence pial vessels.
